Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of nicotinamide in dialysis patients with hyperphosphatemia
2009-015821-34Phase 2Completed
- Sponsor
- Medice
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nicotinamide in hyperphosphatemia (2 arms), sponsored by Medice. Primary endpoint: Serum phosphate level at 4 weeks. Started Jun 2010; status: completed.
02
Drugs
nicotinamide
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2009-015821-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015821-34.